Abstract
Infection rate among intravenous drug users (IDU) is higher than the general public, and is the major cause of morbidity and hospitalization in the IDU population. Epidemiologic studies provide data on increased prevalence of opportunistic bacterial infections such as TB and pneumonia, and viral infections such as HIV-1 and hepatitis in the IDU population. An important component in the intravenous drug abuse population and in patients receiving medically indicated chronic opioid treatment is opioid withdrawal. Data on bacterial virulence in the context of opioid withdrawal suggest that mice undergoing withdrawal had shortened survival and increased bacterial load in response to Salmonella infection. As the body of evidence in support of opioid dependency and its immunosuppressive effects is growing, it is imperative to understand the mechanisms by which opioids exert these effects and identify the populations at risk that would benefit the most from the interventions to counteract opioid immunosuppressive effects. Thus, it is important to refine the existing animal model to closely match human conditions and to cross-validate these findings through carefully controlled human studies. Better understanding of the mechanisms will facilitate the search for new therapeutic modalities to counteract adverse effects including increased infection rates. This review will summarize the effects of morphine on innate and adaptive immunity, identify the role of the mu opioid receptor in these functions and the signal transduction activated in the process. The role of opioid withdrawal in immunosuppression and the clinical relevance of these findings will also be discussed.
Similar content being viewed by others
References
Aceijas C, Stimson GV, Hickman M, Rhodes T, United Nations Reference Group on HIV/AIDS Prevention and Care among IDU in Developing and Transitional Countries (2004) Global overview of injecting drug use and HIV infection among injecting drug users. AIDS 18:2295–2303
Alme B, Carlsson L, Kanerva P, Lundberg G, Persson E, Rydberg U, Bottiger M, Putkonen PO (1987) HIV infection and narcotic addiction. Lakartidningen 84:213–216
Anthony IC, Ramage SN, Carnie FW, Simmonds P, Bell JE (2005) Does drug abuse alter microglial phenotype and cell turnover in the context of advancing HIV infection? Neuropathol Appl Neurobiol 31:325–338
Asakura H, Kawamoto K, Igimi S, Yamamoto S, Makino S (2006) Enhancement of mice susceptibility to infection with Listeria monocytogenes by the treatment of morphine. Microbiol Immunol 50:543–547
Azuma Y, Wang PL, Shinohara M, Ohura K (2000) Immunomodulation of the neutrophil respiratory burst by endomorphins 1 and 2. Immunol Lett 75:55–59
Bafica A, Scanga CA, Equils O, Sher A (2004a) The induction of Toll-like receptor tolerance enhances rather than suppresses HIV-1 gene expression in transgenic mice. J Leukoc Biol 75:460–466
Bafica A, Scanga CA, Schito M, Chaussabel D, Sher A (2004b) Influence of coinfecting pathogens on HIV expression: evidence for a role of Toll-like receptors. J Immunol 172:7229–7234
Banchereau J, Steinman RM (1998) Dendritic cells and the control of immunity. Nature 392:245–252
Beagles K, Wellstein A, Bayer B (2004) Systemic morphine administration suppresses genes involved in antigen presentation. Mol Pharmacol 65:437–442
Berger EA, Murphy PM, Farber JM (1999) Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. Annu Rev Immunol 17:657–700
Bhargava HN, Thomas PT, Thorat S, House RV (1994) Effects of morphine tolerance and abstinence on cellular immune function. Brain Res 642:1–10
Bhaskaran M, Reddy K, Sharma S, Singh J, Radhakrishnan N, Kapasi A, Singhal PC (2001) Morphine-induced degradation of the host defense barrier: role of macrophage injury. J Infect Dis 184:1524–1531
Bhaskaran M, Kapasi AA, Reddy K, Singhal PC (2007) Morphine priming rescues high-dose morphine-induced biological perturbations. J Infect Dis 195:1860–1869
Bidlack JM (2000) Detection and function of opioid receptors on cells from the immune system. Clin Diagn Lab Immunol 7:719–723
Blasig J, Herz A, Reinhold K, Zieglgansberger S (1973) Development of physical dependence on morphine in respect to time and dosage and quantification of the precipitated withdrawal syndrome in rats. Psychopharmacologia 33:19–38
Bokhari SM, Yao H, Bethel-Brown C, Fuwang P, Williams R, Dhillon NK, Hegde R, Kumar A, Buch SJ (2009) Morphine enhances Tat-induced activation in murine microglia. J Neurovirol 15:219–228
Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101:1644–1655
Bonnet MP, Beloeil H, Benhamou D, Mazoit JX, Asehnoune K (2008) The mu opioid receptor mediates morphine-induced tumor necrosis factor and interleukin-6 inhibition in toll-like receptor 2-stimulated monocytes. Anesth Analg 106:1142–1149, table of contents
Borman A, Ciepielewski Z, Wrona D, Stojek W, Glac W, Leszkowicz E, Tokarski J (2009) Small doses of morphine can enhance NK cell cytotoxicity in pigs. Int Immunopharmacol 9:277–283
Borner C, Stumm R, Hollt V, Kraus J (2007) Comparative analysis of mu-opioid receptor expression in immune and neuronal cells. J Neuroimmunol 188:56–63
Borner C, Warnick B, Smida M, Hartig R, Lindquist JA, Schraven B, Hollt V, Kraus J (2009) Mechanisms of opioid-mediated inhibition of human T cell receptor signaling. J Immunol 183:882–889
Boyadjieva NI, Chaturvedi K, Poplawski MM, Sarkar DK (2004) Opioid antagonist naltrexone disrupts feedback interaction between mu and delta opioid receptors in splenocytes to prevent alcohol inhibition of NK cell function. J Immunol. 173:42–49
Breslow JM, Feng P, Meissler JJ, Pintar JE, Gaughan J, Adler MW, Eisenstein TK (2010) Potentiating effect of morphine on oral Salmonella enterica serovar Typhimurium infection is mu-opioid receptor-dependent. Microb Pathog 49:330–335
Brichacek B, Vanpouille C, Kiselyeva Y, Biancotto A, Merbah M, Hirsch I, Lisco A, Grivel JC, Margolis L (2010) Contrasting roles for TLR ligands in HIV-1 pathogenesis. PLoS One 5:e12831
Bryant HU, Bernton EW, Holaday JW (1988) Morphine pellet-induced immunomodulation in mice: temporal relationships. J Pharmacol Exp Ther 245:913–920
Bryant HU, Bernton EW, Kenner JR, Holaday JW (1991) Role of adrenal cortical activation in the immunosuppressive effects of chronic morphine treatment. Endocrinology 128:3253–3258
Burbassi S, Aloyo VJ, Simansky KJ, Meucci O (2008) GTPgammaS incorporation in the rat brain: a study on mu-opioid receptors and CXCR4. J Neuroimmune Pharmacol 3:26–34
Bussiere JL, Adler MW, Rogers TJ, Eisenstein TK (1992) Differential effects of morphine and naltrexone on the antibody response in various mouse strains. Immunopharmacol Immunotoxicol 14:657–673
Bussiere JL, Adler MW, Rogers TJ, Eisenstein TK (1993) Cytokine reversal of morphine-induced suppression of the antibody response. J Pharmacol Exp Ther 264:591–597
Carr DJ, Gebhardt BM, Paul D (1993) Alpha adrenergic and mu-2 opioid receptors are involved in morphine-induced suppression of splenocyte natural killer activity. J Pharmacol Exp Ther 264:1179–1186
Casellas AM, Guardiola H, Renaud FL (1991) Inhibition by opioids of phagocytosis in peritoneal macrophages. Neuropeptides 18:35–40
Chang SL, Beltran JA, Swarup S (2007) Expression of the mu opioid receptor in the human immunodeficiency virus type 1 transgenic rat model. J Virol 81:8406–8411
Chao CC, Sharp BM, Pomeroy C, Filice GA, Peterson PK (1990) Lethality of morphine in mice infected with Toxoplasma gondii. J Pharmacol Exp Ther 252:605–609
Chao CC, Sharp BM, Pomeroy C, Filice GA, Peterson PK (1991) Effects of morphine addiction on the pathogenesis of murine toxoplasmosis. Adv Exp Med Biol 288:223–227
Chapman CR, Lipschitz DL, Angst MS, Chou R, Denisco RC, Donaldson GW, Fine PG, Foley KM, Gallagher RM, Gilson AM, Haddox JD, Horn SD, Inturrisi CE, Jick SS, Lipman AG, Loeser JD, Noble M, Porter L, Rowbotham MC, Schoelles KM, Turk DC, Volinn E, Von Korff MR, Webster LR, Weisner CM (2010) Opioid pharmacotherapy for chronic non-cancer pain in the United States: a research guideline for developing an evidence-base. J Pain 11:807–829
Chuang LF, Chuang TK, Killam KF Jr, Chuang AJ, Kung HF, Yu L, Chuang RY (1994) Delta opioid receptor gene expression in lymphocytes. Biochem Biophys Res Commun 202:1291–1299
Chuang LF, Chuang TK, Killam KF Jr, Qiu Q, Wang XR, Lin JJ, Kung HF, Sheng W, Chao C, Yu L (1995) Expression of kappa opioid receptors in human and monkey lymphocytes. Biochem Biophys Res Commun 209:1003–1010
Clark JD, Shi X, Li X, Qiao Y, Liang D, Angst MS, Yeomans DC (2007) Morphine reduces local cytokine expression and neutrophil infiltration after incision. Mol Pain 3:28
Crawford A, Macleod M, Schumacher T, Corlett L, Gray D (2006) Primary T cell expansion and differentiation in vivo requires antigen presentation by B cells. J Immunol 176:3498–3506
Das S, Kelschenbach J, Cahrboneau R, Barke RA, Roy S (2011) Morphine withdrawal stress and glucocorticoids independently modulate LPS-induced IL-12p40 expression by activating extracellular-signal regulated kinase 1/2. (submitted)
Dinda A, Gitman M, Singhal PC (2005) Immunomodulatory effect of morphine: therapeutic implications. Expert Opin Drug Saf 4:669–675
Donahoe RM, Byrd LD, McClure HM, Brantley M, Wenzel D, Ansari AA, Marsteller F (2001) Effects of morphine on T-cell recirculation in rhesus monkeys. Adv Exp Med Biol 493:89–101
Eisenstein TK, Hilburger ME (1998) Opioid modulation of immune responses: effects on phagocyte and lymphoid cell populations. J Neuroimmunol 83:36–44
Equils O, Faure E, Thomas L, Bulut Y, Trushin S, Arditi M (2001) Bacterial lipopolysaccharide activates HIV long terminal repeat through Toll-like receptor 4. J Immunol 166:2342–2347
Fecho K, Lysle DT (1999) Phenotypic analysis of splenocyte subsets following acute morphine treatment in the rat. Cell Immunol 195:137–146
Feng P, Meissler JJ Jr, Adler MW, Eisenstein TK (2005a) Morphine withdrawal sensitizes mice to lipopolysaccharide: elevated TNF-alpha and nitric oxide with decreased IL-12. J Neuroimmunol 164:57–65
Feng P, Wilson QM, Meissler JJ Jr, Adler MW, Eisenstein TK (2005b) Increased sensitivity to Salmonella enterica serovar Typhimurium infection in mice undergoing withdrawal from morphine is associated with suppression of interleukin-12. Infect Immun 73:7953–7959
Feng P, Rahim RT, Cowan A, Liu-Chen LY, Peng X, Gaughan J, Meissler JJ Jr, Adler MW, Eisenstein TK (2006) Effects of mu, kappa or delta opioids administered by pellet or pump on oral Salmonella infection and gastrointestinal transit. Eur J Pharmacol 534:250–257
Finley MJ, Steele A, Cornwell WD, Rogers TJ (2011) Transcriptional regulation of the major HIV-1 coreceptor, CXCR4, by the {kappa} opioid receptor. J Leukoc Biol
Fleisch F, Zbinden R, Vanoli C, Ruef C (2001) Epidemic spread of a single clone of methicillin-resistant Staphylococcus aureus among injection drug users in Zurich, Switzerland. Clin Infect Dis 32:581–586
Flores LR, Wahl SM, Bayer BM (1995) Mechanisms of morphine-induced immunosuppression: effect of acute morphine administration on lymphocyte trafficking. J Pharmacol Exp Ther 272:1246–1251
Friedman H, Eisenstein TK (2004) Neurological basis of drug dependence and its effects on the immune system. J Neuroimmunol 147:106–108
Frolich N, Dees C, Paetz C, Ren X, Lohse MJ, Nikolaev VO, Zenk MH (2011) Distinct pharmacological properties of morphine metabolites at G(i)-protein and beta-arrestin signaling pathways activated by the human mu-opioid receptor. Biochem Pharmacol 81:1248–1254
Gaveriaux C, Peluso J, Simonin F, Laforet J, Kieffer B (1995) Identification of kappa- and delta-opioid receptor transcripts in immune cells. FEBS Lett 369:272–276
Georges H, Leroy O, Vandenbussche C, Guery B, Alfandari S, Tronchon L, Beaucaire G (1999) Epidemiological features and prognosis of severe community-acquired pneumococcal pneumonia. Intensive Care Med 25:198–206
Gilbert M, MacDonald J, Gregson D, Siushansian J, Zhang K, Elsayed S, Laupland K, Louie T, Hope K, Mulvey M, Gillespie J, Nielsen D, Wheeler V, Louie M, Honish A, Keays G, Conly J (2006) Outbreak in Alberta of community-acquired (USA300) methicillin-resistant Staphylococcus aureus in people with a history of drug use, homelessness or incarceration. CMAJ 175:149–154
Glattard E, Welters ID, Lavaux T, Muller AH, Laux A, Zhang D, Schmidt AR, Delalande F, Laventie BJ, Dirrig-Grosch S, Colin DA, Van Dorsselaer A, Aunis D, Metz-Boutigue MH, Schneider F, Goumon Y (2010) Endogenous morphine levels are increased in sepsis: a partial implication of neutrophils. PLoS One 5:e8791
Gordon RJ, Lowy FD (2005) Bacterial infections in drug users. N Engl J Med 353:1945–1954
Greeneltch KM, Kelly-Welch AE, Shi Y, Keegan AD (2005) Chronic morphine treatment promotes specific Th2 cytokine production by murine T cells in vitro via a Fas/Fas ligand-dependent mechanism. J Immunol 175:4999–5005
Grimm MC, Ben-Baruch A, Taub DD, Howard OM, Resau JH, Wang JM, Ali H, Richardson R, Snyderman R, Oppenheim JJ (1998a) Opiates transdeactivate chemokine receptors: delta and mu opiate receptor-mediated heterologous desensitization. J Exp Med 188:317–325
Grimm MC, Ben-Baruch A, Taub DD, Howard OM, Wang JM, Oppenheim JJ (1998b) Opiate inhibition of chemokine-induced chemotaxis. Ann N Y Acad Sci 840:9–20
Guarner J, Bartlett J, Reagan S, Fischer M, Finn S, O’Briain DS, Black M, Hood J, Zaki SR (2006) Immunohistochemical evidence of Clostridium sp, Staphylococcus aureus, and group A Streptococcus in severe soft tissue infections related to injection drug use. Hum Pathol 37:1482–1488
Gunji N, Nagashima M, Asano G, Yoshino S, (2000) Expression of kappa-opioid receptor mRNA in human peripheral blood lymphocytes and the relationship between its expression and the inflammatory changes in rheumatoid arthritis. Rheumatol Int 19:95–100
Guo CJ, Li Y, Tian S, Wang X, Douglas SD, Ho WZ (2002) Morphine enhances HIV infection of human blood mononuclear phagocytes through modulation of beta-chemokines and CCR5 receptor. J Investig Med 50:435–442
Gureje O, Von Korff M, Simon GE, Gater R (1998) Persistent pain and well-being: a World Health Organization Study in Primary Care. JAMA 280:147–151
Hao YS, Li PF, Zhang FX, Huang DA, Liu XH, Li G (2003) Morphine alleviates early stages of apoptosis in cultured CEM x174 cells infected with simian immunodeficiency virus. Cell Biol Int 27:719–725
Happel C, Steele AD, Finley MJ, Kutzler MA, Rogers TJ (2008) DAMGO-induced expression of chemokines and chemokine receptors: the role of TGF-beta1. J Leukoc Biol 83:956–963
Harari Y, Weisbrodt NW, Moody FG (2006) The effect of morphine on mast cell-mediated mucosal permeability. Surgery 139:54–60
Haverkos HW, Lange WR (1990) From the alcohol, drug abuse, and mental health administration. Serious infections other than human immunodeficiency virus among intravenous drug abusers. J Infect Dis 161:894–902
Heggelund L, Muller F, Lien E, Yndestad A, Ueland T, Kristiansen KI, Espevik T, Aukrust P, Froland SS (2004) Increased expression of toll-like receptor 2 on monocytes in HIV infection: possible roles in inflammation and viral replication. Clin Infect Dis 39:264–269
Hilburger ME, Adler MW, Truant AL, Meissler JJ Jr, Satishchandran V, Rogers TJ, Eisenstein TK (1997) Morphine induces sepsis in mice. J Infect Dis 176:183–188
Hind CR (1990a) Pulmonary complications of intravenous drug misuse. 1. Epidemiology and non-infective complications. Thorax 45:891–898
Hind CR (1990b) Pulmonary complications of intravenous drug misuse. 2. Infective and HIV related complications. Thorax 45:957–961
Houshyar H, Galigniana MD, Pratt WB, Woods JH (2001) Differential responsivity of the hypothalamic-pituitary-adrenal axis to glucocorticoid negative-feedback and corticotropin releasing hormone in rats undergoing morphine withdrawal: possible mechanisms involved in facilitated and attenuated stress responses. J Neuroendocrinol 13:875–886
Hu S, Chao CC, Hegg CC, Thayer S, Peterson PK (2000) Morphine inhibits human microglial cell production of, and migration towards, RANTES. J Psychopharmacol 14:238–243
Hussey HH, Katz S (1950) Infections resulting from narcotic addiction; report of 102 cases. Am J Med 9:186–193
Ignatowski TA, Bidlack JM (1998) Detection of kappa opioid receptors on mouse thymocyte phenotypic subpopulations as assessed by flow cytometry. J Pharmacol Exp Ther 284:298–306
Kaushik KS, Kapila K, Praharaj AK (2011) Shooting up: the interface of microbial infections and drug abuse. J Med Microbiol 60:408–422
Kelschenbach J, Barke RA, Roy S (2005) Morphine withdrawal contributes to Th cell differentiation by biasing cells toward the Th2 lineage. J Immunol 175:2655–2665
Kelschenbach J, Ninkovic J, Wang J, Krishnan A, Charboneau R, Barke RA, Roy S (2008) Morphine withdrawal inhibits IL-12 induction in a macrophage cell line through a mechanism that involves cAMP. J Immunol 180:3670–3679
Kieffer BL, Gaveriaux-Ruff C (2002) Exploring the opioid system by gene knockout. Prog Neurobiol 66:285–306
Kirst A, Wack C, Lutz WK, Eggert A, Kampgen E, Fischer WH (2002) Expression of functional kappa-opioid receptors on murine dendritic cells. Immunol Lett 84:41–48
Kleindienst P, Brocker T (2005) Concerted antigen presentation by dendritic cells and B cells is necessary for optimal CD4 T-cell immunity in vivo. Immunology 115:556–564
Koyuncuoglu H, Gungor M, Ang O, Inanc D, Ang-Kucuker M, Sagduyu H, Uysal V (1988) Aggravation by morphine and D-aspartic acid of pyelonephritis induced by i.v. inoculation of Staphylococcus aureus in rats. Infection 16:42–45
Kraus J, Borner C, Giannini E, Hickfang K, Braun H, Mayer P, Hoehe MR, Ambrosch A, Konig W, Hollt V (2001) Regulation of mu-opioid receptor gene transcription by interleukin-4 and influence of an allelic variation within a STAT6 transcription factor binding site. J Biol Chem 276:43901–43908
Kraus J, Lehmann L, Borner C, Hollt V (2010) Epigenetic mechanisms involved in the induction of the mu opioid receptor gene in Jurkat T cells in response to interleukin-4. Mol Immunol 48:257–263
Kulkarni-Narla A, Walcheck B, Brown DR (2001) Opioid receptors on bone marrow neutrophils modulate chemotaxis and CD11b/CD18 expression. Eur J Pharmacol 414:289–294
Kumar R, Torres C, Yamamura Y, Rodriguez I, Martinez M, Staprans S, Donahoe RM, Kraiselburd E, Stephens EB, Kumar A (2004) Modulation by morphine of viral set point in rhesus macaques infected with simian immunodeficiency virus and simian-human immunodeficiency virus. J Virol 78:11425–11428
Lefkowitz SS, Chiang CY (1975) Effects of certain abused drug s on hemolysin forming cells. Life Sci 17:1763–1767
Levine DP, and Brown PV (2005) Infections in injection drug users. InMandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, pp. 3462–3476. Edited by Mandell, G. L., Bennett, J. E. & Dolin, R.. Philadelphia, PA. : Churchill Livingstone
Li Y, Zhang T, Douglas SD, Lai JP, Xiao WD, Pleasure DE, Ho WZ (2003) Morphine enhances hepatitis C virus (HCV) replicon expression. Am J Pathol 163:1167–1175
Li Y, Sun X, Zhang Y, Huang J, Hanley G, Ferslew KE, Peng Y, Yin D (2009) Morphine promotes apoptosis via TLR2, and this is negatively regulated by beta-arrestin 2. Biochem Biophys Res Commun 378:857–861
Liang-Suo J, Gomez-Flores R, Weber RJ (2002) Immunosuppression induced by central action of morphine is not blocked by mifepristone (RU 486). Life Sci 71:2595–2602
Linde-Zwirble WT, Angus DC (2004) Severe sepsis epidemiology: sampling, selection, and society. Crit Care 8:222–226
Linner KM, Quist HE, Sharp BM (1995) Met-enkephalin-containing peptides encoded by proenkephalin A mRNA expressed in activated murine thymocytes inhibit thymocyte proliferation. J Immunol 154:5049–5060
Liu H, Li H, Guo L, Li M, Li C, Wang S, Jiang W, Liu X, McNutt MA, Li G (2010) Mechanisms involved in phosphatidylinositol 3-kinase pathway mediated up-regulation of the mu opioid receptor in lymphocytes. Biochem Pharmacol 79:516–523
Lugo-Chinchilla AM, Baez D, Velez M, Ildefonso C, Renaud FL (2006) Altered subcellular signaling in murine peritoneal macrophages upon chronic morphine exposure. J Neuroimmunol 176:86–94
Lysle DT, Hoffman KE, Dykstra LA (1996) Evidence for the involvement of the caudal region of the periaqueductal gray in a subset of morphine-induced alterations of immune status. J Pharmacol Exp Ther 277:1533–1540
Ma Y, Li J, Chiu I, Wang Y, Sloane JA, Lu J, Kosaras B, Sidman RL, Volpe JJ, Vartanian T (2006) Toll-like receptor 8 functions as a negative regulator of neurite outgrowth and inducer of neuronal apoptosis. J Cell Biol 175:209–215
Ma J, Wang J, Wan J, Charboneau R, Chang Y, Barke RA, Roy S (2010) Morphine disrupts interleukin-23 (IL-23)/IL-17-mediated pulmonary mucosal host defense against Streptococcus pneumoniae infection. Infect Immun 78:830–837
Madera-Salcedo IK, Cruz SL, Gonzalez-Espinosa C (2011) Morphine decreases early peritoneal innate immunity responses in Swiss-Webster and C57BL6/J mice through the inhibition of mast cell TNF-alpha release. J Neuroimmunol 232:101–107
Madsen L, Labrecque N, Engberg J, Dierich A, Svejgaard A, Benoist C, Mathis D, Fugger L (1999) Mice lacking all conventional MHC class II genes. Proc Natl Acad Sci U S A 96:10338–10343
Mahajan SD, Aalinkeel R, Reynolds JL, Nair BB, Fernandez SF, Schwartz SA, Nair MP (2005a) Morphine exacerbates HIV-1 viral protein gp120 induced modulation of chemokine gene expression in U373 astrocytoma cells. Curr HIV Res 3:277–288
Mahajan SD, Schwartz SA, Aalinkeel R, Chawda RP, Sykes DE, Nair MP (2005b) Morphine modulates chemokine gene regulation in normal human astrocytes. Clin Immunol 115:323–332
Makarenkova VP, Esche C, Kost NV, Shurin GV, Rabin BS, Zozulya AA, Shurin MR (2001) Identification of delta- and mutype opioid receptors on human and murine dendritic cells. J Neuroimmunol 117:68–77
Makman MH, Bilfinger TV, Stefano GB (1995) Human granulocytes contain an opiate alkaloid-selective receptor mediating inhibition of cytokine-induced activation and chemotaxis. J Immunol 154:1323–1330
Mansour A, Fox CA, Akil H, Watson SJ (1995) Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications. Trends Neurosci 18:22–29
Martin JL, Charboneau R, Barke RA, Roy S (2010a) Chronic morphine treatment inhibits LPS-induced angiogenesis: implications in wound healing. Cell Immunol 265:139–145
Martin JL, Koodie L, Krishnan AG, Charboneau R, Barke RA, Roy S (2010b) Chronic morphine administration delays wound healing by inhibiting immune cell recruitment to the wound site. Am J Pathol 176:786–799
Matthes HW, Maldonado R, Simonin F, Valverde O, Slowe S, Kitchen I, Befort K, Dierich A, Le Meur M, Dolle P, Tzavara E, Hanoune J, Roques BP, Kieffer BL (1996) Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene. Nature 383:819–823
McCarthy L, Szabo I, Nitsche JF, Pintar JE, Rogers TJ (2001) Expression of functional μ-opioid receptors during T cell development. J Neuroimmunol 114:173–180
McIlroy MA, Reddy D, Markowitz N, Saravolatz LD (1989) Infected false aneurysms of the femoral artery in intravenous drug addicts. Rev Infect Dis 11:578–585
Mellon RD, Noori NE, Hernandez MC, Bayer BM (2001) Altered T-cell responsiveness in morphine “tolerant” rats: evidence for a potential role of the paraventricular nucleus of the hypothalamus. Adv Exp Med Biol 493:177–185
Menzebach A, Hirsch J, Nost R, Mogk M, Hempelmann G, Welters ID (2004) Morphine inhibits complement receptor expression, phagocytosis and oxidative burst by a nitric oxide dependent mechanism. Anasthesiol Intensivmed Notfallmed Schmerzther 39:204–211
Miyagi T, Chuang LF, Doi RH, Carlos MP, Torres JV, Chuang RY (2000) Morphine induces gene expression of CCR5 in human CEMx174 lymphocytes. J Biol Chem 275:31305–31310
Mohan S, Davis RL, DeSilva U, Stevens CW (2010) Dual regulation of mu opioid receptors in SK-N-SH neuroblastoma cells by morphine and interleukin-1beta: evidence for opioid-immune crosstalk. J Neuroimmunol 227:26–34
Moore K, Dusheiko G (2005) Opiate abuse and viral replication in hepatitis C. Am J Pathol 167:1189–1191
Moorman J, Zhang Y, Liu B, LeSage G, Chen Y, Stuart C, Prayther D, Yin D (2009) HIV-1 gp120 primes lymphocytes for opioid-induced, beta-arrestin 2-dependent apoptosis. Biochim Biophys Acta 1793:1366–1371
Mustelin T, Tasken K (2003) Positive and negative regulation of T-cell activation through kinases and phosphatases. Biochem J 371:15–27
Nath A, Hauser KF, Wojna V, Booze RM, Maragos W, Prendergast M, Cass W, Turchan JT (2002) Molecular basis for interactions of HIV and drugs of abuse. J Acquir Immune Defic Syndr 31(Suppl 2):S62–S69
Nelson CJ, Schneider GM, Lysle DT (2000) Involvement of central μ- but Not δ- or κ-opioid receptors in immunomodulation. Brain Behav Immun 14:170–184
Nugent AL, Houghtling RA, Bayer BM (2011) Morphine suppresses MHC-II expression on circulating B lymphocytes via activation of the HPA. J Neuroimmune Pharmacol 6:130–141
Ocasio FM, Jiang Y, House SD, Chang SL (2004) Chronic morphine accelerates the progression of lipopolysaccharide-induced sepsis to septic shock. J Neuroimmunol 149:90–100
Ohara T, Itoh T, Takahashi M (2005) Immunosuppression by morphine-induced lymphocyte apoptosis: is it a real issue? Anesth Analg 101:1117–1122, table of contents
Palepu A, Tyndall MW, Leon H, Muller J, O’Shaughnessy MV, Schechter MT, Anis AH (2001) Hospital utilization and costs in a cohort of injection drug users. CMAJ 165:415–420
Perez-Castrillon JL, Perez-Arellano JL, Garcia-Palomo JD, Jimenez-Lopez A, De Castro S (1992) Opioids depress in vitro human monocyte chemotaxis. Immunopharmacology 23:57–61
Perlman DC, Salomon N, Perkins MP, Yancovitz S, Paone D, Des Jarlais DC (1995) Tuberculosis in drug users. Clin Infect Dis 21:1253–1264
Peterson PK, Sharp B, Gekker G, Brummitt C, Keane WF (1987) Opioid-mediated suppression of cultured peripheral blood mononuclear cell respiratory burst activity. J Immunol 138:3907–3912
Peterson PK, Gekker G, Brummitt C, Pentel P, Bullock M, Simpson M, Hitt J, Sharp B (1989) Suppression of human peripheral blood mononuclear cell function by methadone and morphine. J Infect Dis 159:480–487
Peterson PK, Sharp BM, Gekker G, Portoghese PS, Sannerud K, Balfour HH Jr (1990) Morphine promotes the growth of HIV-1 in human peripheral blood mononuclear cell cocultures. AIDS 4:869–873
Peterson PK, Gekker G, Hu S, Sheng WS, Molitor TW, Chao CC (1995) Morphine stimulates phagocytosis of mycobacterium tuberculosis by human microglial cells: involvement of a G protein-coupled opiate receptor. Adv Neuroimmunol 5:299–309
Philippe D, Chakass D, Thuru X, Zerbib P, Tsicopoulos A, Geboes K, Bulois P, Breisse M, Vorng H, Gay J, Colombel JF, Desreumaux P, Chamaillard M (2006) Mu opioid receptor expression is increased in inflammatory bowel diseases: implications for homeostatic intestinal inflammation. Gut 55:815–823
Plytycz B, Natorska J (2002) Morphine attenuates pain and prevents inflammation in experimental peritonitis. Trends Immunol 23:345–346
Qian YN, Jin WJ, Wang L, Wang HJ (2005) Effect of different concentrations of morphine and tramadol on the differentiation of human helper T cells in vitro. Br J Anaesth 95:277
Quaglio G, Lugoboni F, Talamini G, Lechi A, Mezzelani P (2002) Prevalence of tuberculosis infection and comparison of multiple-puncture liquid tuberculin test and Mantoux test among drug users. Scand J Infect Dis 34:574–576
Rahim RT, Adler MW, Meissler JJ Jr, Cowan A, Rogers TJ, Geller EB, Eisenstein TK (2002) Abrupt or precipitated withdrawal from morphine induces immunosuppression. J Neuroimmunol 127:88–95
Rahim RT, Meissler JJ, Zhang L, Adler MW, Rogers TJ, Eisenstein TK (2003) Withdrawal from morphine in mice suppresses splenic macrophage function, cytokine production, and costimulatory molecules. J Neuroimmunol 144:16–27
Rahim RT, Feng P, Meissler JJ, Rogers TJ, Zhang L, Adler MW, Eisenstein TK (2004) Paradoxes of immunosuppression in mouse models of withdrawal. J Neuroimmunol 147:114–120
Rahim RT, Meissler JJ Jr, Adler MW, Eisenstein TK (2005) Splenic macrophages and B cells mediate immunosuppression following abrupt withdrawal from morphine. J Leukoc Biol 78:1185–1191
Ripamonti C, Bruera E (1996) Pain and symptom management in palliative care. Cancer Control 3:204–213
Rivera-Amill V, Kumar R, Noel RJ Jr, Garcia Y, Rodriguez IV, Martinez M, Sariol CA, Kraiselburd E, Iszard M, Mukherji M, Kumar S, Giavedoni LD, Kumar A (2010) Short communication: Lack of immune response in rapid progressor morphine-dependent and SIV/SHIV-infected rhesus macaques is correlated with downregulation of TH1 cytokines. AIDS Res Hum Retroviruses 26:919–922
Robinson GM, Thornton NJ, Rout J, Mackenzie N (1987) AIDS–risk behaviours and AIDS knowledge in intravenous drug users. N Z Med J 100:209–211
Rogers TJ, Steele AD, Howard OM, Oppenheim JJ (2000) Bidirectional heterologous desensitization of opioid and chemokine receptors. Ann N Y Acad Sci 917:19–28
Rojavin M, Szabo I, Bussiere JL, Rogers TJ, Adler MW, Eisenstein TK (1993) Morphine treatment in vitro or in vivo decreases phagocytic functions of murine macrophages. Life Sci 53:997–1006
Roy S, Loh HH (1996) Effects of opioids on the immune system. Neurochem Res 21:1375–1386
Roy S, Chapin RB, Cain KJ, Charboneau RG, Ramakrishnan S, Barke RA (1997) Morphine inhibits transcriptional activation of IL-2 in mouse thymocytes. Cell Immunol 179:1–9
Roy S, Barke RA, Loh HH (1998a) MU-opioid receptor-knockout mice: role of mu-opioid receptor in morphine mediated immune functions. Brain Res Mol Brain Res 61:190–194
Roy S, Cain KJ, Charboneau RG, Barke RA (1998b) Morphine accelerates the progression of sepsis in an experimental sepsis model. Adv Exp Med Biol 437:21–31
Roy S, Balasubramanian S, Sumandeep S, Charboneau R, Wang J, Melnyk D, Beilman GJ, Vatassery R, Barke RA (2001a) Morphine directs T cells toward T(H2) differentiation. Surgery 130:304–309
Roy S, Wang JH, Balasubramanian S, Sumandeep R, Charboneau R, Barke R, Loh HH (2001b) Role of hypothalamic-pituitary axis in morphine-induced alteration in thymic cell distribution using mu-opioid receptor knockout mice. J Neuroimmunol 116:147–155
Roy S, Wang J, Gupta S, Charboneau R, Loh HH, Barke RA (2004) Chronic morphine treatment differentiates T helper cells to Th2 effector cells by modulating transcription factors GATA 3 and T-bet. J Neuroimmunol 147:78–81
Roy S, Wang J, Charboneau R, Loh HH, Barke RA (2005) Morphine induces CD4+ T cell IL-4 expression through an adenylyl cyclase mechanism independent of the protein kinase A pathway. J Immunol 175:6361–6367
Roy S, Wang J, Kelschenbach J, Koodie L, Martin J (2006) Modulation of immune function by morphine: implications for susceptibility to infection. J Neuroimmune Pharmacol 1:77–89
Ruff MR, Wahl SM, Mergenhagen S, Pert CB (1985) Opiate receptor-mediated chemotaxis of human monocytes. Neuropeptides 5:363–366
Sacerdote P (2006) Opioids and the immune system. Palliat Med 20(Suppl 1):s9–s15
Saurer TB, Carrigan KA, Ijames SG, Lysle DT (2006a) Suppression of natural killer cell activity by morphine is mediated by the nucleus accumbens shell. J Neuroimmunol 173:3–11
Saurer TB, Ijames SG, Lysle DT (2006b) Neuropeptide Y Y1 receptors mediate morphine-induced reductions of natural killer cell activity. J Neuroimmunol 177:18–26
Scheidegger C, Zimmerli W (1989) Infectious complications in drug addicts: seven-year review of 269 hospitalized narcotics abusers in Switzerland. Rev Infect Dis 11:486–493
Schwab CL, Fan R, Zheng Q, Myers LP, Hebert P, Pruett SB (2005) Modeling and predicting stress-induced immunosuppression in mice using blood parameters. Toxicol Sci 83:101–113
Sedqi M, Roy S, Ramakrishnan S, Elde R, Loh HH (1995) Complementary DNA cloning of a mu-opioid receptor from rat peritoneal macrophages. Biochem Biophys Res Commun 209:563–574
Sharp BM, Keane WF, Suh HJ, Gekker G, Tsukayama D, Peterson PK (1985) Opioid peptides rapidly stimulate superoxide production by human polymorphonuclear leukocytes and macrophages. Endocrinology 117:793–795
Simpkins CO, Dickey CA, Fink MP (1984) Human neutrophil migration is enhanced by beta-endorphin. Life Sci 34:2251–2255
Simpkins CO, Alailima ST, Tate EA, Johnson M (1986) The effect of enkephalins and prostaglandins on O-2 release by neutrophils. J Surg Res 41:645–652
Singh PP, Singal P (2007) Morphine-induced neuroimmunomodulation in murine visceral leishmaniasis: the role(s) of cytokines and nitric oxide. J Neuroimmune Pharmacol 2:338–351
Singh RP, Jhamb SS, Singh PP (2008) Effects of morphine during Mycobacterium tuberculosis H37Rv infection in mice. Life Sci 82:308–314
Song C, Rahim RT, Davey PC, Bednar F, Bardi G, Zhang L, Zhang N, Oppenheim JJ, Rogers TJ (2011) PKC{zeta} mediates {micro}-opioid receptor-induced cross-desensitization of CCR5. J Biol Chem
Staahl C, Dimcevski G, Andersen SD, Thorsgaard N, Christrup LL, Arendt-Nielsen L, Drewes AM (2007) Differential effect of opioids in patients with chronic pancreatitis: an experimental pain study. Scand J Gastroenterol 42:383–390
Stankiewicz E, Wypasek E, Plytycz B (2004) Mast cells are responsible for the lack of anti-inflammatory effects of morphine in CBA mice. Mediators Inflamm 13:365–368
Stanojevic S, Vujic V, Mitic K, Kustrimovic N, Kovacevic-Jovanovic V, Miletic T, Dimitrijevic M (2008) Methionine-enkephalin modulation of hydrogen peroxide (H2O2) release by rat peritoneal macrophages involves different types of opioid receptors. Neuropeptides 42:147–158
Steele AD, Henderson EE, Rogers TJ (2003) Mu-opioid modulation of HIV-1 coreceptor expression and HIV-1 replication. Virology 309:99–107
Suzuki S, Chuang AJ, Chuang LF, Doi RH, Chuang RY (2002a) Morphine promotes simian acquired immunodeficiency syndrome virus replication in monkey peripheral mononuclear cells: induction of CC chemokine receptor 5 expression for virus entry. J Infect Dis 185:1826–1829
Suzuki S, Chuang LF, Yau P, Doi RH, Chuang RY (2002b) Interactions of opioid and chemokine receptors: oligomerization of mu, kappa, and delta with CCR5 on immune cells. Exp Cell Res 280:192–200
Suzuki S, Chuang LF, Doi RH, Chuang RY (2003) Morphine suppresses lymphocyte apoptosis by blocking p53-mediated death signaling. Biochem Biophys Res Commun 308:802–808
Szabo I, Rojavin M, Bussiere JL, Eisenstein TK, Adler MW, Rogers TJ (1993) Suppression of peritoneal macrophage phagocytosis of Candida albicans by opioids. J Pharmacol Exp Ther 267:703–706
Tang SC, Arumugam TV, Xu X, Cheng A, Mughal MR, Jo DG, Lathia JD, Siler DA, Chigurupati S, Ouyang X, Magnus T, Camandola S, Mattson MP (2007) Pivotal role for neuronal Toll-like receptors in ischemic brain injury and functional deficits. Proc Natl Acad Sci U S A 104:13798–13803
Taub DD, Eisenstein TK, Geller EB, Adler MW, Rogers TJ (1991) Immunomodulatory activity of mu- and kappa-selective opioid agonists. Proc Natl Acad Sci U S A 88:360–364
Tegeder I, Geisslinger G (2004) Opioids as modulators of cell death and survival–unraveling mechanisms and revealing new indications. Pharmacol Rev 56:351–369
Thomas PT, House RV, Bhargava HN (1995) Direct cellular immunomodulation produced by diacetylmorphine (heroin) or methadone. Gen Pharmacol 26:123–130
Ting AC, Cheng SW (1997) Femoral pseudoaneurysms in drug addicts. World J Surg 21:783–6; discussion 786–7
Tomassini N, Renaud FL, Roy S, Loh HH (2003) Mu and delta receptors mediate morphine effects on phagocytosis by murine peritoneal macrophages. J Neuroimmunol 136:9–16
Tomassini N, Renaud F, Roy S, Loh HH (2004) Morphine inhibits Fc-mediated phagocytosis through mu and delta opioid receptors. J Neuroimmunol 147:131–133
Tomei EZ, Renaud FL (1997) Effect of morphine on Fc-mediated phagocytosis by murine macrophages in vitro. J Neuroimmunol 74:111–116
Topp L, Iversen J, Wand H, Day C, Kaldor J, Maher L (2008) Representativeness of injecting drug users who participate in HIV surveillance: results from Australia’s needle and syringe program survey. J Acquir Immune Defic Syndr 47:632–638
Tseng RJ, Padgett DA, Dhabhar FS, Engler H, Sheridan JF (2005) Stress-induced modulation of NK activity during influenza viral infection: role of glucocorticoids and opioids. Brain Behav Immun 19:153–164.
Tubaro E, Santiangeli C (1987) Methadone vs morphine: comparison of their effect on phagocytic functions. Int J Immunopharmacol 1987, 79-88
Tubaro E, Borelli G, Croce C, Cavallo G, Santiangeli C (1983) Effect of morphine on resistance to infection. J Infect Dis 148:656–666
Turchan-Cholewo J, Dimayuga FO, Ding Q, Keller JN, Hauser KF, Knapp PE, Bruce-Keller AJ (2008) Cell-specific actions of HIV-Tat and morphine on opioid receptor expression in glia. J Neurosci Res 86:2100–2110
Vallejo R, de Leon-Casasola O, Benyamin R (2004) Opioid therapy and immunosuppression: a review. Am J Ther 11:354–365
van Epps DE, Saland L (1984) Beta-endorphin and met-enkephalin stimulate human peripheral blood mononuclear cell chemotaxis. J Immunol 132:3046–3053
Venkatesan A, Nath A, Ming GL, Song H (2007) Adult hippocampal neurogenesis: regulation by HIV and drugs of abuse. Cell Mol Life Sci 64:2120–2132
Wang J, Charboneau R, Balasubramanian S, Barke RA, Loh HH, Roy S (2001) Morphine modulates lymph node-derived T lymphocyte function: role of caspase-3, -8, and nitric oxide. J Leukoc Biol 70:527–536
Wang J, Barke RA, Charboneau R, Loh HH, Roy S (2003) Morphine negatively regulates interferon-gamma promoter activity in activated murine T cells through two distinct cyclic AMP-dependent pathways. J Biol Chem 278:37622–37631
Wang J, Barke RA, Charboneau R, Roy S (2005) Morphine impairs host innate immune response and increases susceptibility to Streptococcus pneumoniae lung infection. J Immunol 174:426–434
Wang J, Barke RA, Roy S (2007) Transcriptional and epigenetic regulation of interleukin-2 gene in activated T cells by morphine. J Biol Chem 282:7164–7171
Wang J, Barke RA, Charboneau R, Schwendener R, Roy S (2008a) Morphine induces defects in early response of alveolar macrophages to Streptococcus pneumoniae by modulating TLR9-NF-kappa B signaling. J Immunol 180:3594–3600
Wang J, Barke RA, Ma J, Charboneau R, Roy S (2008b) Opiate abuse, innate immunity, and bacterial infectious diseases. Arch Immunol Ther Exp (Warsz) 56:299–309
Wang J, Ma J, Charboneau R, Barke R, Roy S (2011a) Morphine inhibits murine dendritic cell IL-23 production by modulating toll-like receptor 2 and Nod2 signaling. J Biol Chem 286:10225–10232
Wang X, Douglas SD, Peng JS, Zhou DJ, Wan Q, Ho WZ (2006) An in vitro model of morphine withdrawal manifests the enhancing effect on human immunodeficiency virus infection of human T lymphocytes through the induction of substance P. Am J Pathol 169:1663–1670.
Wang X, Ye L, Zhou Y, Liu MQ, Zhou DJ, Ho WZ (2011b) Inhibition of anti-HIV microRNA expression: a mechanism for opioid-mediated enhancement of HIV infection of monocytes. Am J Pathol 178:41–47
Weber RJ, Pert A (1989) The periaqueductal gray matter mediates opiate-induced immunosuppression. Science 245:188–190
Weber RJ, Ikejiri B, Rice KC, Pert A, Hagan AA (1987) Opiate receptor mediated regulation of the immune response in vivo. NIDA Res Monogr 76:341–348
Welters ID, Menzebach A, Goumon Y, Cadet P, Menges T, Hughes TK, Hempelmann G, Stefano GB (2000) Morphine inhibits NF-kappaB nuclear binding in human neutrophils and monocytes by a nitric oxide-dependent mechanism. Anesthesiology 92:1677–1684
West JP, Dykstra LA, Lysle DT (1999) Immunomodulatory effects of morphine withdrawal in the rat are time dependent and reversible by clonidine. Psychopharmacology (Berl) 146:320–327
Wiesli P, Pavlicek V, Perren A, Baechli E, Pfammatter T, Krahenbuhl L, Schulthess G, Schmid C (2006) Recurrent hypoglycaemia in HIV-positive narcotic addicts. Swiss Med Wkly 136:805–810
Yang EV, Glaser R (2002) Stress-induced immunomodulation and the implications for health. Int Immunopharmacol 2:315–324
Yokota T, Uehara K, Nomoto Y (2004) Addition of noradrenaline to intrathecal morphine augments the postoperative suppression of natural killer cell activity. J Anesth 18:190–195
Yossuck P, Nightengale BJ, Fortney JE, Gibson LF (2008) Effect of morphine sulfate on neonatal neutrophil chemotaxis. Clin J Pain 24:76–82
Yukioka H, Rosen M, Evans KT, Leach KG, Hayward MW, Saggu GS (1987) Gastric emptying and small bowel transit times in volunteers after intravenous morphine and nalbuphine. Anaesthesia 42:704–710
Zhang N, Oppenheim JJ (2005) Crosstalk between chemokines and neuronal receptors bridges immune and nervous systems. J Leukoc Biol 78:1210–1214
Zhang T, Li Y, Ho WZ (2006) Drug abuse, innate immunity and hepatitis C virus. Rev Med Virol 16:311–327
Zhang Y, Li H, Li Y, Sun X, Zhu M, Hanley G, Lesage G, Yin D (2011) Essential role of toll-like receptor 2 in morphine-induced microglia activation in mice. Neurosci Lett 489:43–47
Acknowledgement
This work was supported by National Institutes of Health grants NIH RO1 DA12104, RO1 DA022935, KO2 DA015349, R01 DA031202 and P50 DA11806 (S.R.)
Conflict of Interest
No Conflict of Interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Roy, S., Ninkovic, J., Banerjee, S. et al. Opioid Drug Abuse and Modulation of Immune Function: Consequences in the Susceptibility to Opportunistic Infections. J Neuroimmune Pharmacol 6, 442–465 (2011). https://doi.org/10.1007/s11481-011-9292-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11481-011-9292-5